News Articles for "Biogen Idec"
-
Biogen says FDA starts hemophilia drug review
Biogen Idec Inc. said Monday that the Food and Drug Administration is reviewing its experimental drug Eloctate as a treatment for hemophilia A. Its shares...
read more -
Biogen Idec 1Q income rises on lower tax rate
Biogen Idec Inc. said Thursday its net income climbed 41 percent in the first quarter on lower tax rates and improved sales of its multiple sclerosis drug...
read more 
Elan buys back $1B shares for $11.25 a share
Irish drugmaker Elan Corp. PLC said Thursday it had completed its "Dutch auction" stock repurchase, buying back $1 billion in stock for $11.25 per share. ...
read more
Sector Snap: Biotechnology stocks
Shares of major biotechnology stocks are trading around all-time highs, but a Credit Suisse analyst said Thursday that the sector still has room to rise a...
read more